Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer

Gastrointestinal Cancer

Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Treated With Panitumumab in the ASPECCT Study

doi: 10.1158/1078-0432.CCR-18-2072.

Gastrointestinal Cancer

Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, towards assessment of adjuvant therapy efficacy and clinical behavior of recurrences

Clin Cancer Res

Henriksen TV, Tarazona N, Frydendahl A, Reinert T, Gimeno-Valiente F, Carbonell-Asins JA, Sharma S, Renner D, Hafez D, Roda D, Huerta M, Roselló S, Madsen AH, Løve US, Andersen PV, Thorlacius-Ussing O, Iversen LH, Gotschalck KA, Sethi H, Aleshin A, Cervantes A, Andersen CL

doi: 10.1158/1078-0432.CCR-21-2404

Gastrointestinal Cancer

Endoscopic full-thickness resection for early colorectal cancer

Gastrointest Endosc.

Kuellmer A, Mueller J, Caca K, Aepli P, Dakkak D, Schumacher B, Glitsch A, Schäfer C, Wallstabe I, Hofmann C, Erhardt A, Meier B, Bettinger D, Thimme R, Schmidt A; FTRD study group

doi: 10.1016/j.gie.2018.12.025.

Gastrointestinal Cancer

β₆-integrin serves as a novel serum tumor marker for colorectal carcinoma

Int J Cancer.

Bengs S, Becker E, Busenhart P, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, Mamie C, Vavricka SR, von Boehmer L, Knuth A, Tuomisto A, Mäkinen MJ, Hruz P, Turina M, Rickenbacher A, Petrowsky H, Weber A, Frei P, Halama M, Jenkins G, Sheppard D, Croner RS, Christoph J, Britzen-Laurent N, Naschberger E, Schellerer V, Stürzl M, Fried M, Rogler G, Scharl M

doi: 10.1002/ijc.32137.

Gastrointestinal Cancer

Long-term Outcomes of Primary Endoscopic Resection vs Surgery for T1 Colorectal Cancer: A Systematic Review and Meta-analysis

Clin Gastroenterol Hepatol.

Yeh JH, Tseng CH, Huang RY, Lin CW, Lee CT, Hsiao PJ, Wu TC, Kuo LT, Wang WL

doi: 10.1016/j.cgh.2020.05.060.

Gastrointestinal Cancer

Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

doi: 10.1016/j.ejca.2018.10.001.

Gastrointestinal Cancer

Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection

BMC Gastroenterol.

Granata V, Fusco R, de Lutio di Castelguidone E, Avallone A, Palaia R, Delrio P, Tatangelo F, Botti G, Grassi R, Izzo F, Petrillo A

doi: 10.1186/s12876-019-1036-7.

ColonoscopyGastrointestinal Cancer

Post-colonoscopy Colorectal Cancer in Sweden 2003-2012: Survival, Tumor Characteristics, and Risk Factors

Clin Gastroenterol Hepatol.

Forsberg A, Widman L, Sc D MB, Ekbom A, Hultcrantz R

doi: 10.1016/j.cgh.2020.06.010.

Colonoscopy

Predicting the presence of adenomatous polyps during colonoscopy with National Cancer Institute Colorectal Cancer Risk-Assessment Tool

World J Gastroenterol.

Tariq H, Kamal MU, Patel H, Patel R, Ameen M, Elona S, Khalifa M, Azam S, Zhang A, Kumar K, Baiomi A, Shaikh D, Makker J

doi: 10.3748/wjg.v24.i34.3919.

Related content

Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Treated With Panitumumab in the ASPECCT Study

Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, towards assessment of adjuvant therapy efficacy and clinical behavior of recurrences

Endoscopic full-thickness resection for early colorectal cancer

β6-integrin serves as a novel serum tumor marker for colorectal carcinoma

Long-term Outcomes of Primary Endoscopic Resection vs Surgery for T1 Colorectal Cancer: A Systematic Review and Meta-analysis

Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection

Post-colonoscopy Colorectal Cancer in Sweden 2003-2012: Survival, Tumor Characteristics, and Risk Factors

Predicting the presence of adenomatous polyps during colonoscopy with National Cancer Institute Colorectal Cancer Risk-Assessment Tool

β₆-integrin serves as a novel serum tumor marker for colorectal carcinoma